Recombinant Nectin-4 (Enfortumab Biosimilar) antibody

Catalog No. ABIN7597660

The Human Monoclonal anti-Nectin-4 (Enfortumab Biosimilar) antibody has been validated for . It is suitable to detect Nectin-4 (Enfortumab Biosimilar) in samples from Human.

Quick Overview for Recombinant Nectin-4 (Enfortumab Biosimilar) antibody (ABIN7597660)

Target: Nectin-4 (Enfortumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This Nectin-4 (Enfortumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-Nectin-4 (Enfortumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Enfortumab Biosimilar Antibody

Specificity: LNIR, NECTIN4, PRR4, Poliovirus receptor-related protein 4, Nectin cell adhesion molecule 4, Ig superfamily receptor LNIR, Nectin-4, PVRL4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 6.77 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for Nectin-4 (Enfortumab Biosimilar)

Target: Nectin-4 (Enfortumab Biosimilar)

Alternative Name: Enfortumab Biosimilar

Target Type: Biosimilar

Background: LNIR, NECTIN4, PRR4, Poliovirus receptor-related protein 4, Nectin cell adhesion molecule 4, Ig superfamily receptor LNIR, Nectin-4, PVRL4

UniProt: Q96NY8

CAS-No: 1346452-25-2